Warby Parker Inc(WRBY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:35 PM ET (Korea 9/12 05:35)
Full metrics table
| Index | RUT | P/E | 407.08 | EPS (ttm) | 0.06 | Insider Own | 17.39% | Shs Outstand | 107.7M | Perf Week | 6.1% |
| Market Cap | 3.05B | Forward P/E | 41.1 | EPS next Y | 37.6% | Insider Trans | -3.63% | Shs Float | 102.1M | Perf Month | -2.41% |
| Enterprise Value | 3.01B | PEG | 1.09 | EPS next Q | 0.09 | Inst Own | 101.7% | Short Float | 15.96% | Perf Quarter | -4.45% |
| Income | 0.01B | P/S | 3.35 | EPS this Y | 21.52% | Inst Trans | 18.61% | Short Ratio | 5.59 | Perf Half Y | 5.1% |
| Sales | 0.91B | P/B | 7.78 | EPS next 5Y | 37.79% | ROA | 1.05% | Short Interest | 16.30M | Perf YTD | 13.4% |
| Book/sh | 3.18 | P/C | 10.44 | EPS past 3/5Y | - | ROE | 2.06% | 52W High | -20.29% ($31.00) | Perf Year | -10.31% |
| Cash/sh | 2.37 | P/FCF | 140.43 | Sales past 3/5Y | 13.39% 17.23% | ROIC | 1.27% | 52W Low | 65.17% ($14.96) | Perf 3Y | 102.21% |
| Dividend Est. | - | EV/EBITDA | 50.46 | EPS Y/Y TTM | 182.39% | Gross Margin | 52.61% | Volatility(W/M) | 5.24% 5.12% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 3.3 | Sales Y/Y TTM | 10.99% | Oper. Margin | 0.25% | ATR (14) | 1.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.93 | EPS Q/Q | 358.04% | Profit Margin | 0.85% | RSI (14) | 45.56 | Recom | 1.81 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.18 | Sales Q/Q | 9.81% | SMA20 | -2.56% ($25.36) | Beta | 1.91 | Target Price | $30.46 |
| Payout | - | Debt/Eq | 0.64 | Earnings | 2026/8/6 | SMA50 | -5.86% ($26.25) | Rel Volume | 0.69 | Prev Close | $24.3 |
| Employees | 4036 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 63.82% -1.04% | SMA200 | -1.08% ($24.98) | Avg Volume(3M) | 2.91M | Price | $24.71 |
| IPO | 2021/9/29 | Option/Short | Yes/Yes | Trades | 14461 | Volume | 2,010,782 | Change | 1.69% |
Company
WRBY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
👓 This is an American eyewear company that sells glasses and eyewear products. It designs and sells its own eyewear and contact lenses, as well as offering vision exams both online and in stores, and is known for its vertically integrated business model and affordable pricing. It operates in the eyewear industry.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
WRBY makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +21.5% this year.
Tap to view numbers
But it is not cheap
Trading at 407.1 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +102.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 101.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PINK 0.05%
TMFS 0.03%
XRT 0.02%
RETL 0.01%
DBSC 0.01%It ranks #4 in the industry
Based on market cap of $3B.
WRBY $3B PER 407.1
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is WRBY?
WRBY belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of WRBY?
The market cap of WRBY is approximately $3.1B, ranking 1,765 within its sector.
What is the P/E ratio of WRBY?
WRBY has a P/E ratio of approximately 407.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WRBY?
WRBY has recorded a 52-week high of $31.00 and a low of $14.96.
